Ontology highlight
ABSTRACT:
ORGANISM(S): Homo Sapiens
SUBMITTER: Ying Li
PROVIDER: PXD024560 | iProX | Sun Mar 07 00:00:00 GMT 2021
REPOSITORIES: iProX
Meng Huyan H Wu Guowei G Zhao Xinsuo X Wang Anhui A Li Dekang D Tong Yilun Y Jin Taijie T Cao Ye Y Shan Bing B Hu Shichen S Li Ying Y Pan Lifeng L Tian Xiaoxu X Wu Ping P Peng Chao C Yuan Junying J Li Guohui G Tan Li L Wang Zhaoyin Z Li Ying Y
Cell discovery 20210601 1
RIPK1, a death domain-containing kinase, has been recognized as an important therapeutic target for inhibiting apoptosis, necroptosis, and inflammation under pathological conditions. RIPK1 kinase inhibitors have been advanced into clinical studies for the treatment of various human diseases. One of the current bottlenecks in developing RIPK1 inhibitors is to discover new approaches to inhibit this kinase as only limited chemotypes have been developed. Here we describe Necrostatin-34 (Nec-34), a ...[more]